As an Ovarian Cancer survivor, I tried in vain to convince my liberal friends that Obamacare will make it more difficult for cancer patients to receive access to new drugs and treatments. Why would we want to install a UK or Canadian healthcare style system when their survival rates are so much lower than ours, I would ask? I'm not one to say I told ya so but I recently received two alarming emails from the Ovarian Cancer National Alliance, OCNA. I received the first email shortly after Donald Berwick was installed as Obama's controversial Head of Medicare. Provenge, a vaccine to treat the recurrence of prostate cancer, has been approved by the Food and Drug Administration (FDA). The vaccine is made from a patient's own blood cells with cancer cells and an immune boosting substance. ... However, the Centers for Medicare and Medicaid Services (CMS) is still reviewing whether it will cover Provenge, and at what rate.... with respect to Provenge, it appears that CMS is arguing...(Read Full Post)